Business
Respiri (ASX:RSH) share price on watch following FDA approval
The Respiri Ltd (ASX: RSH) share price is on watch today after the company advised it has received United States Food and Drug Administration (FDA) clearance for its Wheezo app.
About Respiri
Respiri is a software-as-a-service (SaaS) company supporting asthma patients to monitor and manage their asthma. The company views that asthma is often under-diagnosed and under-treated, creating a substantial burden to sufferers and their families.
Respiri has created an eHealth SaaS platform, ‘Wheezo’, that uses a device and app to measure, record and monitor asthma symptoms. The device records breath sounds over 30 seconds to be analysed in…
-
Noosa News20 hours agoPill checking to resume in Queensland months after government axed funding
-
Noosa News18 hours agoQueensland girl Millie’s fight for life after magnets tore through her bowel
-
Business23 hours agoWhy Austal, Boss Energy, Harvey Norman, and NextDC shares are charging higher today
-
Noosa News23 hours agoBail hearing told of photos showing ‘severely beaten’ Brisbane man Andrew Burow